About

Transcatheter therapy of structural heart disease is advancing rapidly. Due to the less invasive approach, transcatheter techniques have replaced surgery as the standard procedure for atrial septal defect and patent foramen ovale closure.

Evolving interventional techniques allow treatment of paravalvular leaks, ventricular septal defects and valve replacement, especially the rapid evolution and newer indications for transcatheter aortic valve replacement (TAVR).

Related Articles

Articles

Comments on TARGET FFR and DEFINE-FLOW Trials Presented at TCT Connect 2020

Andreas Seitz, Stefan Baumann, Udo Sechtem,

Published:

Citation: European Cardiology Review 2021;16:e17.

Editorial: The EXCEL Trial

Pablo Avanzas, Juan Carlos Kaski,

Published:

Citation: European Cardiology Review 2021;16:e09.

Bridging the Gap in a Rare Cause of Angina

Sumanth Khadke, Jovana Vidovic, Vinod Patel,

Published:

Citation: European Cardiology Review 2021;16:e05.

Pharmacotherapy in Stable CAD: The ISCHEMIA Trial

Jonathan Yap, Derek P Chew, Gregg Stone,

Published:

Citation: European Cardiology Review 2021;16:e04.